Novel measure of lung function for assessing disease activity in asthma
IntroductionIn asthma, lung function measures are often discordant with clinical features such as disease activity or control.MethodsWe investigated a novel technique that provides a measure (σCL) of unevenness (inhomogeneity) in lung inflation/deflation. In particular, we compared σCL with FEV1% pr...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-05-01
|
Series: | BMJ Open Respiratory Research |
Online Access: | https://bmjopenrespres.bmj.com/content/7/1/e000531.full |
id |
doaj-b32ccc74944a4ff498ea812b739c607e |
---|---|
record_format |
Article |
spelling |
doaj-b32ccc74944a4ff498ea812b739c607e2021-02-01T14:30:16ZengBMJ Publishing GroupBMJ Open Respiratory Research2052-44392020-05-017110.1136/bmjresp-2019-000531Novel measure of lung function for assessing disease activity in asthmaNayia PetousiNick P Talbot0Ian PavordPeter A RobbinsNicholas M J SmithJohn CouperChristopher J FullertonGraham RichmondGus HancockGrant A D Ritchieconsultant in respiratory medicineIntroductionIn asthma, lung function measures are often discordant with clinical features such as disease activity or control.MethodsWe investigated a novel technique that provides a measure (σCL) of unevenness (inhomogeneity) in lung inflation/deflation. In particular, we compared σCL with FEV1% predicted (FEV1%pred) as measures of disease activity in the asthmatic lung.ResultsσCL correlated modestly with FEV1%pred. However, σCL is not simply a proxy for FEV1%pred as the effects of salbutamol on the two parameters were unrelated. Importantly, σCL reflected disease control better than FEV1.DiscussionWe conclude that σCL shows promise as an objective measure of disease activity in asthma.https://bmjopenrespres.bmj.com/content/7/1/e000531.full |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Nayia Petousi Nick P Talbot Ian Pavord Peter A Robbins Nicholas M J Smith John Couper Christopher J Fullerton Graham Richmond Gus Hancock Grant A D Ritchie |
spellingShingle |
Nayia Petousi Nick P Talbot Ian Pavord Peter A Robbins Nicholas M J Smith John Couper Christopher J Fullerton Graham Richmond Gus Hancock Grant A D Ritchie Novel measure of lung function for assessing disease activity in asthma BMJ Open Respiratory Research |
author_facet |
Nayia Petousi Nick P Talbot Ian Pavord Peter A Robbins Nicholas M J Smith John Couper Christopher J Fullerton Graham Richmond Gus Hancock Grant A D Ritchie |
author_sort |
Nayia Petousi |
title |
Novel measure of lung function for assessing disease activity in asthma |
title_short |
Novel measure of lung function for assessing disease activity in asthma |
title_full |
Novel measure of lung function for assessing disease activity in asthma |
title_fullStr |
Novel measure of lung function for assessing disease activity in asthma |
title_full_unstemmed |
Novel measure of lung function for assessing disease activity in asthma |
title_sort |
novel measure of lung function for assessing disease activity in asthma |
publisher |
BMJ Publishing Group |
series |
BMJ Open Respiratory Research |
issn |
2052-4439 |
publishDate |
2020-05-01 |
description |
IntroductionIn asthma, lung function measures are often discordant with clinical features such as disease activity or control.MethodsWe investigated a novel technique that provides a measure (σCL) of unevenness (inhomogeneity) in lung inflation/deflation. In particular, we compared σCL with FEV1% predicted (FEV1%pred) as measures of disease activity in the asthmatic lung.ResultsσCL correlated modestly with FEV1%pred. However, σCL is not simply a proxy for FEV1%pred as the effects of salbutamol on the two parameters were unrelated. Importantly, σCL reflected disease control better than FEV1.DiscussionWe conclude that σCL shows promise as an objective measure of disease activity in asthma. |
url |
https://bmjopenrespres.bmj.com/content/7/1/e000531.full |
work_keys_str_mv |
AT nayiapetousi novelmeasureoflungfunctionforassessingdiseaseactivityinasthma AT nickptalbot novelmeasureoflungfunctionforassessingdiseaseactivityinasthma AT ianpavord novelmeasureoflungfunctionforassessingdiseaseactivityinasthma AT peterarobbins novelmeasureoflungfunctionforassessingdiseaseactivityinasthma AT nicholasmjsmith novelmeasureoflungfunctionforassessingdiseaseactivityinasthma AT johncouper novelmeasureoflungfunctionforassessingdiseaseactivityinasthma AT christopherjfullerton novelmeasureoflungfunctionforassessingdiseaseactivityinasthma AT grahamrichmond novelmeasureoflungfunctionforassessingdiseaseactivityinasthma AT gushancock novelmeasureoflungfunctionforassessingdiseaseactivityinasthma AT grantadritchie novelmeasureoflungfunctionforassessingdiseaseactivityinasthma |
_version_ |
1724315363930275840 |